Rofecoxib, a COX-2 Inhibitor, Lowers C-Reactive Protein and Interleukin-6 Levels in Patients With Acute Coronary Syndromes
Chest - United States
doi 10.1378/chest.125.5.1610
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 2004
Authors
Publisher
Elsevier BV